Marshall Wace »

Silverback Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Silverback Therapeutics

Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 20251M2M100k200k
Value ($)Share countHistorical SPRY position of Marshall Wace Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-12-31 $558k 53k 10.55
2024-09-30 $1.1M 78k 14.50
2023-06-30 $500k 75k 6.70
2023-03-31 $257k 39k 6.51
2022-12-31 $273k 32k 8.53
2021-09-30 $2.7M 276k 9.98

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Nvidia Corp Common Stock (NVDA)
Tesla Common Stock (TSLA)
Unitedhealth Grp Common Stock (UNH)
Boston Scientifc Common Stock (BSX)
Meta Platforms-a Common Stock (META)
Alphabet Inc-a Common Stock (GOOGL)
Flutter Enter-di Common Stock (FLUT)
Visa Inc-class A Common Stock (V)
Uber Technologie Common Stock (UBER)
Johnson&johnson Common Stock (JNJ)
Ferrari Nv Common Stock (RACE)

View all positions for Marshall Wace

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics